M, V. et al. 2025. Targeting Metabolic Pathways for Neurodegeneration: The Emerging Role of Anti-Diabetic and Lipid-Lowering Agents. International Journal of Allied Medical Sciences and Clinical Research. 13, 4 (Nov. 2025), 633–642. DOI:https://doi.org/10.61096/ijamscr.v13.iss4.2025.633-642.